Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Dean Foods, Bruker, and More Stocks With Recent Insider Purchases

Page 1 of 2

Our database of insider trading filings allows us to pick out companies that have seen recent insider purchases- studies show that on average stocks bought by insiders tend to beat the market– and take a brief look at the company to see if it might be worth investigating further. It’s impossible to buy every stock that insiders are buying, but it’s certainly possible to use insider buying as a screen to identify potential stock picks. Here are five stocks that insiders have been buying recently:

RENAISSANCE TECHNOLOGIES

The former CEO of Dean Foods Company (NYSE:DF), who currently manages spinout WhiteWave but still sits on Dean’s Board of Directors, bought 10,000 shares of Dean at an average price of $17.25. The spinout makes comparisons to a year ago difficult, but Wall Street analysts apparently expect improvement at the business in 2013 as their forward earnings estimates- which imply a P/E of only 13- depend on a better bottom line than the company reported last quarter. Renaissance Technologies, whose success since inception has made founder Jim Simons a multi-billionaire, reported a position of 2.6 million shares at the end of the third quarter (see more stock picks from Renaissance Technologies). We’re not sure that Dean is a better buy than other packaged food companies.

Frank Laukien, the CEO of Bruker Corporation (NASDAQ:BRKR), increased his holdings of the company by buying 50,000 shares on December 7th at about $14 per share. Bruker provides scientific and technical instruments. Revenue and earnings were up in the third quarter of 2012 compared to the same period in 2011, after having been down in the first six months of the year. Value investor Joel Greenblatt initiated a position in Bruker between July and September (check out Greenblatt’s favorite stocks). Bruker trades at 24 times trailing earnings, and even though last quarter was a strong improvement we think that it’s probably best to watch the stock for now and wait for continued improvements before buying.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!